API
ABBV icon

Advisor Partners II’s AbbVie ABBV Stock Holding History

Advisor Partners II’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$12.3M Buy
82,528
+3,303
+4% +$485K 0.49% 28
2023
Q2 		$10.7M Sell
79,225
-650
-0.8% -$95.3K 0.5% 31
2023
Q1 		$12.7M Buy
79,875
+3,841
+5% +$587K 0.7% 22
2022
Q4 		$12.3M Buy
76,034
+8,655
+13% +$1.33M 0.76% 20
2022
Q3 		$9.04M Buy
+67,379
New +$9.67M 0.68% 22

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Advisor Partners II's ABBV Position: Q3 2023 in Review

Advisor Partners II increased its AbbVie (ABBV) stake by 4.2% in Q3 2023, buying an estimated $485K and bringing the position to 82,528 shares worth $12.3M. The position accounts for 0.49% of the portfolio, ranked #28.

Advisor Partners II first reported a position in ABBV in Q3 2022 and has held it in 5 quarters since. The position peaked at $12.7M in Q1 2023. 3,108 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

  • Advisor Partners II held 82,528 shares of AbbVie worth $12.3M as of Q3 2023.
  • Advisor Partners II bought 3,303 AbbVie shares in Q3 2023, an estimated $485K.
  • AbbVie made up 0.49% of Advisor Partners II's portfolio in Q3 2023, its #28 holding.
  • Advisor Partners II first reported a position in AbbVie in Q3 2022 and has held it in 5 quarters since.
  • Advisor Partners II's AbbVie position peaked at $12.7M in Q1 2023.
  • 3,108 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on Advisor Partners II's 13F filing for Q3 2023, filed 26 Oct 2023.